doi: 10.1186/ar2700 84 DongJLiuCLuJWangLXieSJiLet al
Strategically , however, it may be one of the most interesting launches of the year
Assessments during treatment included standard laboratory testing, serum HCV RNA, vital signs, electrocardiography, and symptom-directed physical examinations
Therefore, therapies attempting to depress ACE2 should not impact the ACE1/ACE2 ratio 11
To determine when the cytosolic glyoxylate shunt becomes activated, II values were monitored during the transition from high CO 2 and normal light conditions to ambient CO 2 and high light conditions
Future large-scale, well-designed clinical trials will be essential to confirm their therapeutic potential, clarify the contribution of metabolic versus immunological effects, and define their role within the treatment algorithm of PsO and PsA